Centerline Biomedical
Cleveland, US · Delaware corporation · 2 known investors
Centerline Biomedical develops IOPS®, a 510(k)-cleared endovascular navigation technology that provides real-time 3D image guidance for physicians performing catheterization and other endovascular procedures. The technology is designed to reduce radiation exposure and improve procedural accuracy for interventional cardiologists, vascular surgeons, and other interventionalists.
Founders & leadership
VG
Vikash GoelinFounder · CTO | Operations ♦ Precision Care ♦ Health IT for Minimally Invasive Surgery ♦ Investor Relations
GK
Gulam KhanExecutive
IE
Indrani EglestonExecutive
PR
Phil RackliffeExecutive
VK
Vinod K. GoelNamed on SEC filing
Board
MW
Michael WhitmanBoard director
TS
Todd SchwarzingerBoard director
MW
Mitch WolfBoard director
AM
Arnaud MarieBoard director
AS
Akhil SaklechaBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$71.8M disclosed across 4 rounds · 2015–2025
▶$10.8MraisedApr 2025 · 8 investors · BiotechnologyRule 506(b)
▶$10.8MraisedApr 2025 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael WhitmanDirector
- Todd SchwarzingerDirector
- Mitch WolfDirector
- Gulam KhanExecutive Officer, Director
- Arnaud MarieDirector
- Indrani EglestonExecutive Officer
- Offering amount
- $15M
- Amount sold
- $10.8M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.7MraisedNov 2023 · 65 investors · BiotechnologyRule 506(b)
▶$13.7MraisedNov 2023 · 65 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jim ZalarDirector
- Karen ShanahanDirector
- Jai N. GuptaExecutive Officer, Director
- Vinod K. GoelExecutive Officer, Director
- Gulam KhanExecutive Officer
- Vikash GoelExecutive Officer
- Offering amount
- $13.7M
- Amount sold
- $13.7M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.7MraisedNov 2023 · 106 investors · BiotechnologyRule 506(b)
▶$12.7MraisedNov 2023 · 106 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Phil RackliffeExecutive Officer, Director
- Vikash GoelExecutive Officer
- Jai N. GuptaDirector
- Vinod K. GoelExecutive Officer, Director
- Jim ZalarDirector
- Gulam KhanExecutive Officer
- Offering amount
- $12.7M
- Amount sold
- $12.7M
- Sales commissions
- $846.6K
- Placement agents
- Paulson Investment Company, LLC
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34.7MraisedNov 2023 · 22 investors · BiotechnologyRule 506(b)
▶$34.7MraisedNov 2023 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vikash GoelExecutive Officer
- Vinod K. GoelExecutive Officer
- Todd SchwarzingerDirector
- Mitch WolfDirector
- Gulam KhanExecutive Officer
- Akhil SaklechaDirector
- Phil RackliffeExecutive Officer, Director
- Offering amount
- $34.7M
- Amount sold
- $34.7M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlapPlushCare45 shared keywordsPlushCare is a telehealth service that connects patients with board-certified primary care doctors and therapists through an app for virtual appointments, prescriptions, and ongoing care. It covers weight management, urgent care, pediatric care, chronic disease treatment, online therapy, and prescription discounts, serving patients across all 50 U.S. states.
Honeybee Health37 shared keywordsHoneybee Health is a mail-order pharmacy based in California that fills prescription and over-the-counter medications, selling generic drugs at transparent, low prices without insurance. It serves patients directly as well as telehealth platforms and practitioners through a prescription fulfillment partnership program, and can also fill prescriptions for pets.
Walgreens35 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Sesame34 shared keywordsSesame is a telehealth marketplace that connects patients with board-certified providers for cash-pay medical visits without insurance, with prices shown upfront and visits starting at $34. It offers online consultations across a range of care needs through independently owned provider practices using its platform.
Doctronic30 shared keywordsDoctronic builds an AI system trained on peer-reviewed medical evidence to provide 24/7 medical triage and consultation, achieving 99.2% alignment with board-certified clinicians. The platform serves patients seeking instant healthcare guidance with no insurance requirement, anonymity, and HIPAA compliance.
Medscape30 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Companies competing with Centerline Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2018 | $223.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Centerline Biomedical do?
- Centerline Biomedical develops IOPS®, a 510(k)-cleared endovascular navigation technology that provides real-time 3D image guidance for physicians performing catheterization and other endovascular procedures. The technology is designed to reduce radiation exposure and improve procedural accuracy for interventional cardiologists, vascular surgeons, and other interventionalists.
- Who founded Centerline Biomedical?
- Centerline Biomedical was founded by Vikash Goel.
- Who are Centerline Biomedical's investors?
- Centerline Biomedical's investors include JobsOhio Ventures, Jumpstart Ventures.
- How much funding has Centerline Biomedical raised?
- Centerline Biomedical has disclosed $71.8M raised across 4 rounds.
- Where is Centerline Biomedical headquartered?
- Centerline Biomedical is headquartered in Cleveland, US.